Embed Size (px)
Citation preview
ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University
Simon BerryCEO and co-founder
ColaLife is a charity registered in the UKCharity number: 1142516
• Small, independent and catalytic• Focus on saving children’s lives• Looking for global impact through
• Innovation• Generating robust evidence• Sharing findings and learning• Influencing healthcare strategies
• No commercial interest
2009
2010
2011
2012
2013
1985What is ColaLife and who am I?
Who, how, when
Positive aspects
Negative aspects
The story so far The role of academia
ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016
The future plans
2 31
Who, how, when
Positive aspects
Negative aspects
The story so far The role of academia
ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016
The future plans
2 31
Diarrhoea
19% of infectious disease deaths
Malaria
15% of infectious disease deaths
AIDS
4%
Source: Liu et al (2015) Global, regional, and national causes of child mortality in 2000–13, with projections to inform post-2015 priorities: an updated systematic analysis. The Lancet.
1
1
1
1
1
<1%
1
1
Source http://guardian.co.uk
1
1
1
1
1
1
1
Kit Yamoyo
Washing Powder
Eggs
Biscuits
Cola – but not Coca-Cola
Bread
1
1
1
1
45%of children in trial areas received ORS/Zinc.
1
Dec-11
Dec-15
Dec-13
Dec-12
Dec-14
Set-up
Trial
Transition
Scale-up
The ColaLife timeline 1
Aug-12
Sep-13
The COTZ trialResearch Design & Methodology
Quasi-experimental, pre-test, post test designBaseline, midline and endline surveys
Target groups: Care-givers of under-5 children and private community retailers
Four Districts – two intervention districts and two comparator districts
Sample sizes:625 HH per district40 retailers per district
impact Mothers in underserved rural communities increase use of ORS and Zinc in home treatment of diarrhoea
purposeTarget communities in two under-served rural districts have improved access to ORS and Zinc
outputs
Profit-driven supply chains improve availability of ADKs (anti-diarrhoea kits) in targeted communities in two underserved rural districts
Mothers/care-givers demonstrate awareness of ADKs and the benefits of the contents (ORS, Zinc and Soap)
access = ADK in the hand of an aware mother/care-giver
Availability = ADK in stock in retail outlets at community level
Generating robust evidence - the COTZ results framework
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.
2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.
2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.
93%of Kit Yamoyo users mixed ORS correctly. Only 60% do when given 1 litre sachets.
60%Only 60% of mothers mixed ORS correctly when given 1 litre sachets.
0Nobody sold ORS or Zinc in the private sector.
Stock-outs in the public sector were common.
<1%of children received the correct treatment for diarrhoea
7.3kmWas the average distance to ORS.
>26kkits sold into the two remote rural trial areas in 12 months.
45%of children in trial areas received ORS/Zinc. Up from a baseline of <1%. Comparator sites stayed at <1%.
2.4kmThe distance to ORS/Zinc in the trial areas was reduced by two-thirds from 7.3km to 2.4km.
93%of Kit Yamoyo users mixed ORS correctly. Only 60% do when given 1 litre sachets.
Dec-11
Dec-15
Dec-13
Dec-12
Dec-14
Set-up
Trial
Transition
Scale-up
The ColaLife timeline 1
Feb-15
1
1
1
1
1
1
1
Who, how, when
Positive aspects
Negative aspects
The story so far The role of academia
ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016
The future plans
2 31
Harry Truman once said that “actions are the seeds of fate”. I hope you will consider thise-mail to be one of those seeds.
2
Who, how, when
Positive aspects
Negative aspects
The story so far The role of academia
ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016
The future plans
2 31
Positive aspects | Academic rigor and expertise 2
Positive aspects | Credibility 2
Positive aspects | Dissemination channels available 2
Who, how, when
Positive aspects
Negative aspects
The story so far The role of academia
ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016
The future plans
2 31
Negative aspects | Academic timescales
Aug-13 Aug-14 Aug-15 Aug-16
Trial finished
Dissertation defense
Publication on website
2
Negative aspects | Academic timescales
Aug-13 Aug-14 Aug-15 Aug-16
Trial finished
Dissertation defence
Publication on website
Meanwhile…1 child dies every minute from diarrhoea in sub-Saharan Africa
2
Negative aspects | Open source/original research tension
Negative aspects | Narrow focus
Product Innovation and Human-Centered Design for
Global Health Delivery: Improving Effective Use of
Oral Rehydration Salts Through the Introduction of
an Innovative Diarrhea Treatment Kit Impact of Emulating Commercial, Private-Sector Value-Chains on Access to ORS and Zinc for Childhood Diarrhea in Rural Zambia: Evaluation of the ColaLife Trial
Serving the Underserved: A Description of Rural,
Commercial General Stores as Community-Level
Providers of Public Health Commodities in Zambia
2
Who, how, when
Positive aspects
Negative aspects
The story so far The role of academia
ColaLife – Cross-sector partnerships – new paradigmsStakeholder Engagement Event, Middlesex University6 July 2016
The future plans
2 31
Future plans and ideas| Complementary dissemination
3
Future plans and ideas| Open source the trial data3
Questions
• Is the open data idea of any interest?• Is there any precedent for this?
• Would academics engage?• Would students engage?• How should we best promote this?• How do we engage Zambian academics?• How could we best support this?
3
Isenberg Family Charitable Foundation
The ColaLife funders past and present – thank you
